{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:39:48Z","timestamp":1783471188492,"version":"3.55.0"},"reference-count":48,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,7,1]]},"DOI":"10.1210\/jcem.87.7.8736","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:08:23Z","timestamp":1389200903000},"page":"3019-3022","source":"Crossref","is-referenced-by-count":69,"title":["Hepatic Steatosis, Insulin Resistance, and Adipose Tissue Disorders"],"prefix":"10.1210","volume":"87","author":[{"given":"Abhimanyu","family":"Garg","sequence":"first","affiliation":[{"name":"Division of Nutrition and Metabolic Diseases Department of Internal Medicine and the Center for Human Nutrition The University of Texas Southwestern Medical Center at Dallas Dallas, Texas 75390-9052"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Misra","sequence":"additional","affiliation":[{"name":"Division of Nutrition and Metabolic Diseases Department of Internal Medicine and the Center for Human Nutrition The University of Texas Southwestern Medical Center at Dallas Dallas, Texas 75390-9052"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041118230106500_R1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2001.25540","article-title":"Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.","volume":"121","author":"Dixon","year":"2001","journal-title":"Gastroenterology"},{"key":"2019041118230106500_R2","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1210\/jcem.84.5.5661","article-title":"Liver pathology and the metabolic syndrome X in severe obesity.","volume":"84","author":"Marceau","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041118230106500_R3","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"2019041118230106500_R4","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/j.1572-0241.2000.03241.x","article-title":"Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history?","volume":"95","author":"Cotrim","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"2019041118230106500_R5","first-page":"462","article-title":"Relative risk of hepatocellular carcinoma in cirrhosis due to fatty liver disease: a study based on incidental hepatocellular carcinoma in liver transplant receipients.","volume":"34","author":"Nair","year":"2001","journal-title":"Hepatology"},{"key":"2019041118230106500_R6","first-page":"458","article-title":"Hepatocellular carcinoma, liver failure and liver mortality in obesity-related cryptogenic cirrhosis.","volume":"34","author":"Ratziu","year":"2001","journal-title":"Hepatology"},{"key":"2019041118230106500_R7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"2019041118230106500_R8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1590-8658(01)80091-8","article-title":"Insulin resistance in non-alcoholic steatohepatitis.","volume":"33","author":"Comert","year":"2001","journal-title":"Dig Liver Dis"},{"key":"2019041118230106500_R9","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"key":"2019041118230106500_R10","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"2019041118230106500_R11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/jhep.2002.30692","article-title":"NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome.","volume":"35","author":"Chitturi","year":"2002","journal-title":"Hepatology"},{"key":"2019041118230106500_R12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3904\/kjim.1998.13.1.10","article-title":"Role of hyperinsulinemia and glucose intolerance in the pathogenesis of nonalcoholic fatty liver in patients with normal body weight.","volume":"13","author":"Lee","year":"1998","journal-title":"Korean J Intern Med"},{"key":"2019041118230106500_R13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/jhep.2002.30690","article-title":"Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association.","volume":"35","author":"Pagano","year":"2002","journal-title":"Hepatology"},{"key":"2019041118230106500_R14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0016-5085(94)90235-6","article-title":"Nonalcoholic steatohepatitis: an expanded clinical entity.","volume":"107","author":"Bacon","year":"1994","journal-title":"Gastroenterology"},{"key":"2019041118230106500_R15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/01.ATV.10.4.493","article-title":"\u201cPortal\u201d adipose tissue as a generator of risk factors for cardiovascular disease and diabetes.","volume":"10","author":"Bjorntorp","year":"1990","journal-title":"Arteriosclerosis"},{"key":"2019041118230106500_R16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1172\/JCI118083","article-title":"Relationship of generalized and regional adiposity to insulin sensitivity in men.","volume":"96","author":"Abate","year":"1995","journal-title":"J Clin Invest"},{"key":"2019041118230106500_R17","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2337\/diab.45.12.1684","article-title":"Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM.","volume":"45","author":"Abate","year":"1996","journal-title":"Diabetes"},{"key":"2019041118230106500_R18","first-page":"E977","article-title":"Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo","volume":"276","author":"Szczepaniak","year":"1999","journal-title":"Am J Physiol"},{"key":"2019041118230106500_R19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0730-725X(94)92543-7","article-title":"Quantification of liver fat using magnetic resonance spectroscopy.","volume":"12","author":"Thomsen","year":"1994","journal-title":"Magn Reson Imaging"},{"key":"2019041118230106500_R20","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1007\/BF01070758","article-title":"Fatty liver: biochemical and clinical considerations.","volume":"20","author":"Hoyumpa","year":"1975","journal-title":"Am J Dig Dis"},{"key":"2019041118230106500_R21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00004424-199304000-00006","article-title":"Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography.","volume":"28","author":"Longo","year":"1993","journal-title":"Invest Radiol"},{"key":"2019041118230106500_R22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0168-8278(97)80288-7","article-title":"Noninvasive in vivo quantitative assessment of fat content in human liver.","volume":"27","author":"Ricci","year":"1997","journal-title":"J Hepatol"},{"key":"2019041118230106500_R23","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1210\/jcem.87.7.8638","article-title":"Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.","volume":"87","author":"Seppa\u0308la\u0308-Lindroos","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041118230106500_R24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1037\/1082-989X.7.1.19","article-title":"On the practice of dichotomization of quantitative variables.","volume":"7","author":"MacCallum","year":"2002","journal-title":"Psychol Methods"},{"key":"2019041118230106500_R25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1037\/0033-2909.113.1.181","article-title":"Bivariate median splits and spurious statistical significance.","volume":"113","author":"Maxwell","year":"1993","journal-title":"Psychol Bull"},{"key":"2019041118230106500_R26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.7326\/0003-4819-136-2-200201150-00009","article-title":"Reporting on statistical methods to adjust for confounding: a cross-sectional survey","volume":"136","author":"Mullner","year":"2002","journal-title":"Ann Intern Med"},{"key":"2019041118230106500_R27","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Non alcoholic fatty liver disease.","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"key":"2019041118230106500_R28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0002-9343(99)00414-3","article-title":"Lipodystrophies.","volume":"108","author":"Garg","year":"2000","journal-title":"Am J Med"},{"key":"2019041118230106500_R29","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM197607222950410","volume":"295","journal-title":"N Engl J Med"},{"key":"2019041118230106500_R30","first-page":"47","article-title":"Congenital generalized lipodystrophy. Report on one case, with special reference to postmortem findings.","volume":"84","author":"Berge","year":"1976","journal-title":"Acta Pathol Microbiol Scand"},{"key":"2019041118230106500_R31"},{"key":"2019041118230106500_R32","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/00007890-200104150-00012","article-title":"Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence after liver transplantation.","volume":"71","author":"Cauble","year":"2001","journal-title":"Transplantation"},{"key":"2019041118230106500_R33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng880","article-title":"AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34.","volume":"31","author":"Agarwal","year":"2002","journal-title":"Nat Genet"},{"key":"2019041118230106500_R34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng585","article-title":"Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13.","volume":"28","author":"Magre","year":"2001","journal-title":"Nat Genet"},{"key":"2019041118230106500_R35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/hmg\/9.1.109","article-title":"Nuclear lamin A\/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy.","volume":"9","author":"Cao","year":"2000","journal-title":"Hum Mol Genet"},{"key":"2019041118230106500_R36","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/302836","article-title":"Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A\/C.","volume":"66","author":"Speckman","year":"2000","journal-title":"Am J Hum Genet"},{"key":"2019041118230106500_R37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/72807","article-title":"LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy.","volume":"24","author":"Shackleton","year":"2000","journal-title":"Nat Genet"},{"key":"2019041118230106500_R38","first-page":"408","article-title":"A novel heterozygous mutation in peroxisome proliferator-activated receptor-\u03b3 gene in a patient with familial partial lipodystrophy.","volume":"87","author":"Agarwal","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041118230106500_R39","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/hmg\/11.7.769","article-title":"A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies.","volume":"11","author":"Lloyd","year":"2002","journal-title":"Hum Mol Genet"},{"key":"2019041118230106500_R40","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1111\/j.1572-0241.2000.03297.x","article-title":"Serum leptin levels in patients with nonalcoholic steatohepatitis.","volume":"95","author":"Uygun","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"2019041118230106500_R41","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1111\/j.1572-0241.1999.01549.x","article-title":"Relationship between serum leptin and fatty liver in Japanese male adolescent university students.","volume":"94","author":"Tobe","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"2019041118230106500_R42","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1210\/jcem.84.10.5999","article-title":"Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects.","volume":"84","author":"Ozata","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041118230106500_R43","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/32911","article-title":"A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction.","volume":"392","author":"Clement","year":"1998","journal-title":"Nature"},{"key":"2019041118230106500_R44","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/43185","article-title":"Congenital leptin deficiency is associated with severe early-onset obesity in humans","volume":"387","author":"Montague","year":"1997","journal-title":"Nature"},{"key":"2019041118230106500_R45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ng0398-213","article-title":"A leptin missense mutation associated with hypogonadism and morbid obesity.","volume":"18","author":"Strobel","year":"1998","journal-title":"Nat Genet"},{"key":"2019041118230106500_R46","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin- replacement therapy for lipodystrophy.","volume":"346","author":"Arioglu Oral","year":"2002","journal-title":"N Engl J Med"},{"key":"2019041118230106500_R47"},{"key":"2019041118230106500_R48","first-page":"161","article-title":"Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.","volume":"50","author":"Peterson","year":"2002","journal-title":"J Investig Med"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/87\/7\/3019\/9155216\/jcem3019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T11:59:00Z","timestamp":1746100740000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/87\/7\/3019\/2846456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,1]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2002,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.87.7.8736","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7,1]]}}}